Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
30 April 2024 - E1367
Rapid detection of imipenem/relebactam susceptibility/resistance in Pseudomonas aeruginosa
Maxime Bouvier, Mohamed Bachtrazi, Laurent Poirel, Patrice Nordmann
30 April 2024 - LB018
Inhibition of the outer membrane protein OprF: a novel target to counteract carbapenem resistance in Pseudomonas aeruginosa
Patrice Nordmann, Nicolas Helsens, Dirk Bumann, Mustafa Sadek, Laurent Poirel, Jacqueline Findlay
29 April 2024 - P1727
In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA
Jacqueline Findlay, Gabriele Bianco, Matteo Boattini, Patrice Nordmann
29 April 2024 - E1088
The emerging concern of IMP-10 being resistant to the only IMP-type metallo-ß-lactamase inhibitor, xeruborbactam
Christophe Le Terrier, Samanta Freire, Patrice Nordmann, Laurent Poirel,
29 April 2024 - E1083
Susceptibility to ceftazidime-avibactam, imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam, cefepime-taniborbactam and cefiderocol of Escherichia coli strains producing broad-spectrum ß-lactamases: about the effect of PBP3 modificat
Christophe Le Terrier, Patrice Nordmann, Chloé Buchs, Laurent Poirel,
29 April 2024 - P1418
Molecular analysis of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Switzerland 2022-2023
Jacqueline Findlay, Otavio Hallal Ferreira Raro, Laurent Poirel, Patrice Nordmann
29 April 2024 - P1512
In vitro activity of newly-developed ß-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with aztreonam against metallo-ß-lactamase producing Escherichia coli clinical isolates
Clement Viguier, Samanta Freire, Maxime Bouvier, Laurent Poirel, Patrice Nordmann,
29 April 2024 - P1751
MultiRapid NP test for detecting concomitantly susceptibility and resistance of last resort novel antibiotics available to treat multidrug-resistant Enterobacterales infections
Patrice Nordmann, Maxime Bouvier, Auriane Kerbol, Laurent Poirel, Otávio Raro
29 April 2024 - P1792
Rapid Combo ESBL/Carba NP test for rapid detection of expanded-spectrum ß-lactamase and carbapenemase producers in Enterobacterales
Clement Viguier, Auriane Kerbol, Maxime Bouvier, Laurent Poirel, Patrice Nordmann,
29 April 2024 - E1085
Relative inhibitory activities of newly-developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone ß-lactamase inhibitors, against broad-spectrum ampC ß-lactamases
Christophe Le Terrier, Patrik Mlynárčik, Mustafa Sadek, Patrice Nordmann, Laurent Poirel,
29 April 2024 - P1725
ACM-like enzymes, new subclass B3 metallo-ß-lactamases identified in Acinetobacter spp.
Clement Viguier, Claire Bertelli, Petros Liakopoulos, Trestan Pillonel, Jacqueline Findlay, Laurent Poirel, Gilbert Greub, Patrice Nordmann,
29 April 2024 - P1699
First report of resistance to aztreonam/avibactam and to cefiderocol in NDM-5 producers E.coli in Algeria
Mohamed Azzedine Bachtarzi, Soumia Bekktache, Maxime Bouvier, Wahiba Amhis, Samir Gourari, Auriane Kerbol, Laurent Poirel, Patrice Nordmann
29 April 2024 - P1560
Evaluation of a new gradient MIC test for aztreonam/avibactam (AZA) susceptibility testing of Enterobacterales
Maxime Bouvier, Laurent Poirel, Auriane Kerbol, Véronique Sauvonnet, Edwige Pillon, Christine Franceschi, Gilles Zambardi, Network Nara, Patrice Nordmann
28 April 2024 - P2292
In vitro activity of newly-developed ß-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with broad-spectrum cephalosporins against AmpC overproducing clinical isolates of Pseudomonas aeruginosa
Christophe Le Terrier, Patrice Nordmann, Laurent Poirel,
28 April 2024 - P2291
Relative inhibitory activities of the broad-spectrum ß-lactamase inhibitor xeruborbactam against metallo-ß-lactamases
Christophe Le Terrier, Clement Viguier, Patrice Nordmann, Laurent Poirel,
28 April 2024 - E0552
Dynamic hollow-fibre studies of meropenem combined with fosfomycin in four clinical K. pneumoniae isolates expressing KPC-2/KPC-3 carbapenemases
Aneeq Farooq, Miklas Martens, Jean-Winoc Decousser, Patrice Nordmann, Sebastian G. Wicha
18 April 2023 - E1176
The emergence of blaGES-type extended-spectrum β-lactamases among Pseudomonas aeruginosa clinical isolates in Switzerland and characterisation of the novel variant GES-57
Laurent Poirel, Alaaeldin Mohamed Saad, Mustafa Sadek, Patrice Nordmann
18 April 2023 - E1323
In vitro evaluation of the interaction between meropenem/fosfomycin and meropenem/vaborbactam/fosfomycin in a clinical multi-drug resistant K. pneumoniae strain expressing blaKPC-2
Aneeq Farooq, Niklas Kroemer, Jean-Winoc Decousser, Julien Buyck, Nicolas Grégoire, Patrice Nordmann, Sebastian G. Wicha
17 April 2023 - O0781
blaGES-52, a novel GES-type β-lactamase conferring resistance to ceftazidime/avibactam and ceftolozane/tazobactam combinations in Pseudomonas aeruginosa
Mustafa Sadek, Alaaeldin Mohamed Saad, Claudine Fournier, Patrice Nordmann, Laurent Poirel
17 April 2023 - P2243
Hollow fiber study assessing synergy of ceftazidime/avibactam and fosfomycin in a clinical E. coli expressing beta-lactamase and carbapenemase genes
Niklas Kroemer, Aneeq Farooq, Jean-Winoc Decousser, Julien Buyck, Nicolas Grégoire, Patrice Nordmann, Sebastian Wicha
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.